BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright ©The Author(s) 2025.
World J Clin Cases. Nov 6, 2025; 13(31): 110624
Published online Nov 6, 2025. doi: 10.12998/wjcc.v13.i31.110624
Table 1 Melanoma-associated acute liver failure cases
Ref.
Clinical presentation
History of cancer
Diagnosis method of liver disease
Treatment
Outcome
Current caseDiffuse abdominal pain, jaundice, hepatic encephalopathy; progressive ALF with multi-organ dysfunctionNo prior cancer history; possible uveal melanoma based on visual symptoms; no autopsyLiver biopsy; HMB-45-positive melanomaSupportive ICU care (intubation, dialysis, vasopressors); considered for transplant until result of biopsyDeath on day 7
O’Neill et al[3], 2024RUQ pain, myalgia, nausea, subjective fevers; fulminant ALFPreviously excised cutaneous melanoma (in situ) on upper back, 1 year priorHistopathological diagnosis via core biopsy of left axillary lymph node (MART1, SOX10, HMB45-positive)Dual immunotherapy (nivolumab + ipilimumab), IV terlipressin, ICU supportDeath on day 17 post-presentation due to refractory encephalopathy and hepatorenal syndrome
Lee et al[4], 2022Nausea, vomiting, RUQ and LUQ pain, dyspepsia; fulminant ALFNo known history of melanoma; presumed first presentation, later verified suspicious skin lesionsLiver biopsy (S-100, HMB45, MART1-positive); stomach biopsy supportiveSupportive care; no specific antitumor therapy reportedDeath shortly after liver biopsy; multiple organ failure before workup for primary site completed
Schlevogt et al[7], 2017Right flank pain; rapid deterioration to ALF with renal failure and encephalopathyMalignant melanoma of right flank (3 years prior), recurrent cutaneous metastases; colorectal carcinoma resected 6 months priorLiver biopsy (S100-positive; HMB45/MART1-negative)BRAF-inhibitor (Vemurafenib) + MEK-inhibitor (Cobimetinib)Death after one week 7 days; autopsy confirmed diffuse hepatic infiltration
Escobar-Valdivia et al[5], 2017RUQ pain, jaundice, weight loss, blindness in left eye; rapid ALF with encephalopathyUndiagnosed uveal (choroidal) melanoma; visual impairment to blindness over 2 months, history revealed pigmented eye lesion 1 year priorPost-mortem histopathology (liver and eye); coagulopathy precluded biopsy ante-mortemSupportive care (FFP, vitamin K); no tumor-directed therapyDeath from multiorgan failure 4th in-hospital day; confirmed metastatic uveal melanoma on autopsy
Tanaka et al[11], 2015Left hand necrotic ulcer, erythema on trunk, no encephalopathy; later developed ALFNo known history of melanoma; diagnosed post-mortem as melanoma of unknown primary originPost-mortem histopathology and immunohistochemistry (HMB-45, S100-positive)Palliative care; patient not eligible for systemic therapy due to poor performance statusDeath on day 47; diffuse hepatic and splenic infiltration by melanoma confirmed on autopsy
Mashayekhi et al[12], 2014Jaundice, abdominal pain, oliguria; rapid ALF with multiorgan failureSuspicious skin lesion (mole on back) noted 10 days before admission, not yet diagnosed or treatedPost-mortem histopathology; liver, heart, lung, kidney, bladder infiltrated with melanomaSupportive care (antibiotics, fluids, inotropes); no tumor-directed therapy before deathDeath on day 3; widespread multiorgan metastatic melanoma confirmed on autopsy
Bellolio et al[10], 2013Abdominal pain, jaundice, acholic stools, dark urine; rapid progression to fulminant hepatic failureHistory of breast cancer treated 5 years prior; no known melanomaPost-mortem histopathology; liver, spleen, and lymph nodes infiltrated with melanoma; HMB-45 and S-100-positiveSupportive care; rapid deterioration precluded biopsy or targeted therapyDeath shortly after admission; melanoma of unknown primary confirmed at autopsy
Tanaka et al[13], 2004Malaise, anorexia, abdominal distension, edema; ALF and encephalopathy, death within hoursNo prior history; melanoma of unknown primary origin diagnosed post-mortemPost-mortem histopathology; massive hepatic infiltration, melanoma cells in mesenteric lymph nodesSupportive care only; rapid deterioration precluded therapeutic interventionDeath on hospital day 7; massive liver involvement, no primary site found on autopsy
Montero et al[8], 2002Jaundice, nausea, vomiting, general malaise; ALF with encephalopathy and renal failureSupraciliary melanoma treated 18 months prior (Clark II, < 1 mm depth, negative margins)Transjugular liver biopsy; diffuse sinusoidal infiltration by melanoma, HMB-45-positiveStandard liver failure therapy; no antitumor interventionDeath on day 10; progressive hepatic encephalopathy and renal dysfunction
Te et al[6], 1999Nausea, vomiting, RUQ pain, malaise; fulminant hepatic failure with encephalopathy and renal failureScalp lesion biopsied 2 months prior; initially non-diagnostic, later confirmed as melanomaPercutaneous liver biopsy (HMB-45, S-100-positive); scalp mass re-biopsy-confirmed melanomaSupportive therapy; chemotherapy deferred due to rapid deteriorationDeath within 24 hours of encephalopathy onset; extensive sinusoidal infiltration confirmed histologically
Bouloux et al[9], 1986Hypochondrial pain, nausea, vomiting, jaundice, encephalopathy; rapid onset ALF and hepatorenal syndromePreviously treated nodular melanoma (Clark IV, 5 mm depth) of right scapula; in situ melanoma of sacrumPost-mortem histopathology; liver almost entirely replaced by melanoma, confirmed microscopicallySupportive care (vitamin K, neomycin, lactulose); no tumor-specific therapy givenDeath on day 10; diffuse liver infiltration confirmed on autopsy